Evidence map›Paper›PMID 39624082›Full record

ArticleCancer drug resistance (Alhambra, Calif.)2024

Fra-1 affects chemotherapy sensitivity by inhibiting ferroptosis in gastric cancer cells.

Feng Zeng, Jiaying Cao, Yan Chen, Jingqiong Tang, Qian He, Shan Liao, Lin Liang, Wentao Li, Siyi Liu, Gengqiu Luo and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer drug resistance (Alhambra, Calif.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Feng ZengCancer Research Institute, Basic School of Medicine, Central South University, Changsha 410011, Hunan, China.
Jiaying CaoCancer Research Institute, Basic School of Medicine, Central South University, Changsha 410011, Hunan, China.
Yan ChenCancer Research Institute, Basic School of Medicine, Central South University, Changsha 410011, Hunan, China.
Jingqiong TangCancer Research Institute, Basic School of Medicine, Central South University, Changsha 410011, Hunan, China.
Qian HeDepartment of Radiation Oncology, Hunan Cancer Hospital & the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China.
Shan LiaoDepartment of Pathology, The Third Xiangya Hospital of Central South University, Changsha 410013, Hunan, China.
Lin LiangCancer Research Institute, Basic School of Medicine, Central South University, Changsha 410011, Hunan, China.
Wentao LiCancer Research Institute, Basic School of Medicine, Central South University, Changsha 410011, Hunan, China.
Siyi LiuCancer Research Institute, Basic School of Medicine, Central South University, Changsha 410011, Hunan, China.
Gengqiu LuoDepartment of Pathology, Xiangya Hospital, Basic School of Medicine, Central South University, Changsha 410008, Hunan, China.
Yanhong ZhouCancer Research Institute, Basic School of Medicine, Central South University, Changsha 410011, Hunan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chemotherapy resistanceferroptosisFra-1G6PDGastric cancerpentose phosphate pathway

Identifiers

PMID39624082
PMCPMC11609144

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.